Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2004-04-30
2009-02-17
Jiang, Dong (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C435S069100, C435S320100, C435S325000, C435S007100, C536S023500
Reexamination Certificate
active
07491803
ABSTRACT:
A human-derived human anti-human IL-18 antibody of the present invention is an antibody against human IL-18, the antibody including: an H-chain complementarity determining region consisting of (a) a polypeptide consisting of amino-acid sequences represented by SEQ ID NOS: 4 to 6, or (b) a polypeptide which is a mutant of the polypeptide (a) and which serves as the H-chain complementarity determining region; and an L-chain complementarity determining region against human interleukin-18 consisting of (c) a polypeptide consisting of amino-acid sequences represented by SEQ ID NOS: 10 to 12, or (d) a polypeptide which is a mutant of the polypeptide (c) and which serves as the L-chain complementarity determining region. This makes it possible to provide a human anti-human IL-18 antibody and a method for using the antibody.
REFERENCES:
patent: 4732863 (1988-03-01), Tomasi et al.
patent: 5695760 (1997-12-01), Faanes et al.
patent: 5994511 (1999-11-01), Lowman et al.
patent: 6290957 (2001-09-01), Lowman et al.
patent: 7138501 (2006-11-01), Ruben et al.
patent: 2001/0024831 (2001-09-01), Der Maur et al.
patent: 2002/0054878 (2002-05-01), Lowman et al.
patent: 2002/0128450 (2002-09-01), Nishida et al.
patent: 2003/0096306 (2003-05-01), Maur et al.
patent: 2003/0103978 (2003-06-01), Deshpande et al.
patent: 2003/0149244 (2003-08-01), Lowman et al.
patent: 1267307 (2000-09-01), None
patent: 0 974 600 (2000-01-01), None
patent: 05-304987 (1993-11-01), None
patent: 2000-236884 (A) (2000-09-01), None
patent: WO-99/09063 (1999-02-01), None
patent: WO-00/56771 (2000-09-01), None
patent: WO 01/58956 (2001-08-01), None
patent: WO 01/62285 (2001-08-01), None
patent: WO 01/62932 (2001-08-01), None
patent: WO 03/076472 (2003-09-01), None
Ignatovich et al., “Dominance of Intrinsic Genetic Factors in Shaping the Human Immunoglobulin VλRepertoire”, J. Mol. Biol. 294:457-465 (1999).
Soos, “Identification of natural antibodies to interleukin-18 in the sera of normal humans and three nonhuman primate species”, Clinical Immunology, 109:188-196 (2003).
Haruki Okamura et al., “Cloning of a New Cytokine that includes IFN- y Production by T cells”, Nature, vol. 378:88-91 (Nov. 2, 1995).
Tomohiro Yoshimoto et al., “Interleukin 18 together with Interleukin 12 Inhibits IgE Production by Induction of Interferon- y Production from Activated B Cells”, Proc. Natl. Acad. Sci. USA, vol. 94:3948-3953 (Apr. 1997).
Kenji Nakanishi et al., “Interleukin-18 Regulates Both TH1 and TH2 Responses”, Annu. Rev. Immunol. 19:423-474 (2001).
Tomohiro Yoshimoto et al., “IL-18, Although Antiallergic When Administered with IL-12, Stimulates IL-4 and Histamine Release by Basophils”, PNAS, 96(24):13962-13966(Nov. 23, 1999).
Tomohiro Yoshimoto et al., “IL-18 Induction of IgE: Dependence on CD4+T cells, IL-4 and STAT6”, Nature Immunology, 1(2):132-137 (Aug. 2000).
Tomohiro Yoshimoto et al., “Nonredundant Roles for CD 1 d-Restricted Natural Killer T Cells and Conventional CD4+T Cells in the Induction of Immunoglobulin E Antibodies in Response to Interleukin 18 Treatment of Mice”, The Journal of Experimental Medicine, 197(8):997-1005 (Apr. 21, 2003).
Hiroshi Konishi et al., “IL-18 Contributes to the Spontaneous Development of Atopic Dermatitis-Like Inflammatory Skin Lesion Independently of IgE/stat6 under Specific Pathogen-Free Conditions”, PNAS, 99(17):11340-11345 (Aug. 20, 2002).
Yong GU et al., “Activation of Interferon- y Inducing Factor Mediated by Interleukin-1 (3 Converting Enzyme”, Science, 275: 206-209 (Jan. 10, 1997).
Kei-ichi Yamanaka et al., “Skin-Specific Caspase-I-Transgenic Mice Show Cutaneous Apoptosis and pre-Endotoxin Shock Condition with a High Serum Level of IL-18”, The Journal of Immunology, pp. 997-1003 (2000).
Kiyoshi Takeda et al., “Essential Role of Stat6 in IL-4 Signalling”, Nature, 380(6575):627-630(Apr. 18, 1996).
Hiroko Tsutsui et al., “IL-18 Accounts for Both TNF- a—and Fas Ligand-mediated Hepatotoxic pathways in Endotoxin-Induced Liver Injury in Mice”, The Journal of Immunology, pp. 3961-3967(1997).
Hiroko Tsutsui et al., “Caspase-1-Independent, Fas/Fas Ligand-Mediated IL-18 Secretion from Macrophages Causes Acute Liver Injury in Mice”, Immunity, 11:359-367 (Sep. 1999).
Hiroko Tsutsui et al., Pathophysiological Roles of Interleukin-18 in Inflammatory Liver Diseases, Immunological reviews, 174:, 192-209 (2000).
Shau-ping LEI et al., “Characterization of theErwinia carotovora pelBGene and its Product Pectate Lyase”, Journal of Bacteriology, pp. 4379-4383 (Sep. 1987).
Takahiro Fukumoto et al., “Peptide Mimics of the CTLA4-Binding Domain Stimulate T -Cell Proliferation”, Nature Biotechnology, 16:267-270 (Mar. 1998).
Takaaki Sugimoto et al., “Interleukin 18 Acts on Memory T Helper Cells Type 1 to Induce Airway Inflammation and Hyperresponsiveness in a Naive Host Mouse”, J. Exp. Med., 199(4):535-545 (Feb. 16, 2004).
Henry Milgrom, et al., “Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody”, the New England Journal of Medicine, 341(26):1966-1973 (Dec. 23, 1999).
James D. Marks et al., “By-passing Immunization Human Antibodies from V -gene Libraries Displayed on Phage”, J. Mol. Biol., 222:581-597 (1991).
Kouji Tominaga et al., “IL-12 Synergizes with IL-18 or IL-1 (3 for IFN- y Production from human T Cells”, International Immunology, 12(2):151-160 (2000).
Yuji Ito et al., Human Antibody Engineering for Molecular Targeting Therapy,: Bio Industry, Jul. 2003, pp. 34-42.
Eric Tse et al., “Intracellular Antibody Capture Technology: Application to Selection of Intracellular Antibodies Recognising the BCR-ABL Oncogenic Protein,” J. Mol. Biol., vol. 317, 2002, pp. 85-94.
M. Taniguchi et al., “Characterization of anti-human interleukin-18 (IL-18)/interferon-y-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA”, Journ. of Immun. Meth., vol. 206, pp. 107-113 (1997).
Nakanishi Kenji
Nakashima Toshihiro
Sugimura Kazuhisa
Conlin David G.
Edwards Angell Palmer & & Dodge LLP
Japan Science & Technology Agency
Jiang Dong
Juridical Foundation The Chemo-Sero-Therapeutic Research Institu
LandOfFree
Human anti-human interleukin-18 antibody, fragment thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human anti-human interleukin-18 antibody, fragment thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human anti-human interleukin-18 antibody, fragment thereof... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4124781